A major discovery in cancer investigation is occurring with the use of nanobodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently disabled in many types of malignancies, resulting https://sitesrow.com/story12011282/mini-antibodies-restore-p53-new-promising-hope-for-cancer-therapy